Inventor
Davinder Gill
Inventor
Andover, MA, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07KPeptides26%
A61KPreparations for medical, dental or toiletry purposes23%
C08BPolysaccharides4%
C12NMicroorganisms or enzymes4%
C07HSugars3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
B01DSeparation1%
C08HDerivatives of natural macromolecular compounds1%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
PatentTitleYear
10,556,000Thermostable spray dried rotavirus vaccine formulation and process thereof202010,532,093Thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof202010,183,962Synthetic oligomers of 201910,105,438Process of conjugation and novel synthetic oligosaccharide-protein conjugates obtained thereof201810,011,662Downstream process for purifying polysaccharides20189,902,771'Anti-5T4 antibodies and uses thereof'20189,644,025'Immunotherapy regimes dependent on ApoE status'20179,272,030'Use of tau to monitor immunotherapy'20168,759,495'Anti-5T4 antibodies and uses thereof'20148,470,993'Nucleic acid encoding antibody to human IL-22'20138,187,603'Antibodies to human IL-22'20128,182,817'Antibodies to human IL-22'20128,178,097'Methods of treatment utilizing binding proteins of the interleukin-21 receptor'20128,163,884'Interleukin-21 receptor binding proteins'20128,044,178'Anti-5T4 antibodies and uses thereof'20117,943,342'Nucleic acids encoding IL-13 binding agents'20117,901,684'Antibodies against human IL-22 and uses therefor'20117,750,122'Anti-TrkB monoclonal antibodies and uses thereof'20107,597,888'Glycoprotein VI and uses thereof'20097,501,121'IL-13 binding agents'20097,101,549'Glycoprotein VI and uses thereof'20066,989,144'Glycoprotein VI antibodies and uses thereof'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2011Based in Burlington, MA, US· patent location history
2010–2018Patents assigned to WYETH LLC (13)· patent assignee history
2010–2018Based in Andover, MA, US· patent location history
2011–2013Patents assigned to MEDIMMUNE LTD (5)· patent assignee history
2012–2017Patents assigned to GILL DAVINDER (5)· patent assignee history
2012–2013Patents assigned to VALGE-ARCHER VIIA (4)· patent assignee history
2018–2020Patents assigned to MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD (5)· patent assignee history
2018–2020Based in New Delhi, IN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| WYETH LLC | 13 | 2010–2018 |
| GILL DAVINDERself | 5 | 2012–2017 |
| MEDIMMUNE LTD | 5 | 2011–2013 |
| MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD | 5 | 2018–2020 |
| VALGE-ARCHER VIIA | 4 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Andover, Massachusetts, US | 12 | 2010–2018 |
| New Delhi, IN | 5 | 2018–2020 |
| Burlington, Massachusetts, US | 5 | 2006–2011 |